Corton Capital Inc. Macrogenics Inc Transaction History

Corton Capital Inc.

  • $38.2 Million
  • Q3 2025

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023
SELL
$4.48 - $6.19 $254,472 - $351,604
-56,802 Reduced 77.09%
16,876 $78,000
Q2 2023

Aug 14, 2023
SELL
$4.62 - $7.54 $7,613 - $12,425
-1,648 Reduced 2.19%
73,678 $394,000
Q1 2023

May 15, 2023
BUY
$4.82 - $7.24 $363,071 - $545,360
75,326 New
75,326 $540,000

About MACROGENICS INC

MGNX Quotes by TradingView
  • Ticker MGNX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 61,458,800
  • Market Cap $94.6M
  • Description
  • MacroGenics, Inc., a biopharmaceutical company, develops and commercializes antibody-based therapeutics to treat cancer in the United States. Its approved product is MARGENZA (margetuximab-cmkb), a human epidermal growth factor receptor 2 (HER2) receptor antagonist indicated, in combination with chemotherapy, for the treatment of adult patients ...
More about MGNX
Track This Portfolio

Track Corton Capital Inc. Portfolio

Follow Corton Capital Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Corton Capital Inc., based on Form 13F filings with the SEC.

News

Stay updated on Corton Capital Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email